Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05468034 · ClinicalTrials.gov registry record · NA
Exercise in Metastatic Breast Cancer: EMBody
A NA study of Breast Cancer and Indolent Metastatic Breast Cancer, sponsored by Indiana University.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 6
- Study locations
NCT05468034 is a NA study of Breast Cancer and Indolent Metastatic Breast Cancer that is actively recruiting participants, run by Indiana University. The registered enrollment target is 100 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The trial reports 6 study locations across 3 states.
The verdict
NCT05468034, a NA study of Breast Cancer and Indolent Metastatic Breast Cancer, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to study exercise in a novel population with indolent MBC (no progression on current therapy in prior 12 months and not receiving cytotoxic chemotherapy). The study team hypothesizes that delivering virtual, supervised, progressive intensity aerobic and resistance training exercise for 16 weeks in this population will significantly improve 1) cardiorespiratory fitness, functional status, and sarcopenia (low muscle mass), all established predictors of survival, and 2) patient- reported outcomes.
Conditions Studied
Interventions
- BEHAVIORAL Exercise Intervention
Study Locations (6)
Indiana
- IU Health West - Avon
- IU Health Joe and Shelly Schwarz Cancer Center - Carmel
- Indiana University Melvin & Bren Simon Cancer Center - Indianapolis
- Sidney and Lois Eskenazi Hospital - Indianapolis
Connecticut
- Yale Cancer Center - New Haven
Massachusetts
- Dana-Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-04-26 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05468034
The ClinicalTrials.gov registry entry for NCT05468034 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Exercise Intervention is the first listed.
NCT05468034 reports 6 study locations spanning 3 distinct geographic areas - top geographies include Indiana, Connecticut, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05468034 about?
NCT05468034 is a clinical study titled "Exercise in Metastatic Breast Cancer: EMBody". The purpose of this study is to study exercise in a novel population with indolent MBC (no progression on current therapy in prior 12 months and not receiving cytotoxic chemotherapy). The study team hypothesizes that delivering virtual, supervised, progressive intensity aerobic and resistance traini...
What is the current status of trial NCT05468034?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-04-26. Estimated completion is 2027-12.
What conditions does trial NCT05468034 study?
This clinical trial studies the following conditions: Breast Cancer, Indolent Metastatic Breast Cancer.
What interventions are being tested in trial NCT05468034?
The interventions under investigation include: Exercise Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05468034?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05468034 being conducted?
This trial has 6 study locations across Connecticut, Indiana, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.